Jul 01, 2020
Donald Trump AMLO will meet on July 8 and 9 in the US
This news has been received from: cvbj.biz
All trademarks, copyrights, videos, photos and logos are owned by respective news sources. News stories, videos and live streams are from trusted sources.
Days of the meeting between Donald Trump and Andrés Manuel López Obrador (AMLO) are announced Mexican Foreign Minister Marcelo Ebrard says that it will be on July 8 and 9 in the United States They will celebrate the entry into force of the new trade agreement between Mexico, the United States and Canada ( T-MEC)
Mexican Foreign Minister Marcelo Ebrard reported on Tuesday that the working visit of the President of Mexico, Andrés Manuel López Obrador (AMLO), to the United States to see Donald Trump, will take place on July 8 and 9, according to the EFE news agency.
“I confirm that we received an invitation from the Government of the United States for an Official Work Visit on July 8 and 9 next,” Ebrard said in a message on Twitter.
“Information early tomorrow, July 1, the day the T-MEC comes into force,” added the Mexican foreign minister. The information was released in various media.
Image taken from Twitter @m_ebrard
López Obrador declared on Monday that the visit to his US counterpart, Donald Trump, to celebrate the entry into force of the new trade agreement between Mexico, the United States and Canada (T-MEC) does not make him a “vendepatrias.”
“I have no conscience problems because I go to the United States if I have always, throughout my life, maintained that Mexico is a free, independent and sovereign country all the time. I am not a vendor, to put it clearly, ”he said at his daily conference.
To see the video click here.
Image taken from Twitter @azucenau
López Obrador’s trip to Washington will be his first trip abroad since he is president.
The visit of the Mexican president has sparked controversy as some voices say that a weakened Donald Trump could use his presence there to campaign ahead of the November elections.
“It is going to be a political meeting in the good sense of what politics is, which has to do with my faculties, which gives me, which gives me, the Constitution,” he replied before acknowledging that he does not know if the Canadian President Justin Trudeau.
Just last week the same Foreign Secretary announced that it was Mexico who proposed the meeting in Washington between the three signatories of the Free Trade Agreement (T-MEC).
Andrés Manuel López Obrador reported that during his visit to the United States where he will meet with President Donald Trump, he will not request credit, and he ruled out meeting with Joe Biden, the Democratic Party’s presidential candidate, because “it would not be correct to speak with candidates.”
At a press conference, and at an express question, the head of the federal Executive pointed out that his visit to Washington has the sole purpose of witnessing the beginning of the Treaty between Mexico, the United States and Canada (T-MEC).
“We do not need credits, we have healthy public finances, that is a difference from what happened before when the crisis that President (Ernesto) Zedillo faced had a rescue of the United States, they made 20 billion dollars available to us, we had to leave mortgaged oil, that does not happen now, we do not have that need, “he said.
“So I am not going to do that, I am not going to apply for credit, I am going to participate in witnessing the beginning of the Treaty that I consider will help us a lot to the three nations, Canada, the United States and Mexico. That’s basically what I’m going for, that’s why I’m not going to speak, it wouldn’t be correct to speak with candidates because it’s a work visit ”.
And he added: “I am going to meet with the President of the United States and if he decides, the Prime Minister of Canada (Justin Trudeau) would also be there, but they are going to solve that.”
Image taken from Twitter @Excelsior
News Source: cvbj.biz
Judge Theodore Chuang Rules Women Can Get Abortion Pill Without Doctor Visit
SILVER SPRING, Maryland (AP) — A federal judge agreed Monday to suspend a rule that requires women during the COVID-19 pandemic to visit a hospital, clinic or medical office to obtain an abortion pill.
U.S. District Judge Theodore Chuang, an Obama appointee based in Maryland, concluded that the “in-person requirements” for patients seeking medication abortion care impose a “substantial obstacle” to abortion patients and are likely unconstitutional under the circumstances of the pandemic.
“Particularly in light of the limited timeframe during which a medication abortion or any abortion must occur, such infringement on the right to an abortion would constitute irreparable harm,” the judge wrote in his 80-page decision.District Judge Theodore Chuang was appointed in 2014.
Judge Chuang made headlines in 2017 for being one of a trio of judges who struck down President Trump’s Executive Orders Executive Order 13769 and Executive Order 13780 – the so-called “Muslim Travel Ban.”
For now, Chuang’s ruling will allow healthcare providers to arrange for mifepristone to be mailed or delivered to patients during the public health emergency declared by the secretary of the U.S. Department of Health and Human Services. The U.S. Food and Drug Administration approved mifepristone to be used in combination with a second drug, misoprostol, to end an early pregnancy or manage a miscarriage.
“By causing certain patients to decide between forgoing or substantially delaying abortion care, or risking exposure to COVID-19 for themselves, their children, and family members, the In-Person Requirements present a serious burden to many abortion patients,” Chuang wrote.
The American College of Obstetricians and Gynecologists and other groups sued HHS and the FDA in May to challenge the rule.
Skye Perryman, chief legal officer for the American College of Obstetricians and Gynecologists, said the FDA’s restrictions on mifepristone are not medically necessary and “do not advance the health and safety of patients.”
“Today’s ruling recognizes the hardship and undue burden that many women have faced obtaining essential health care during the COVID-19 pandemic,” Perryman said.
Plaintiffs’ attorneys from the American Civil Liberties Union argued that the FDA’s in-person requirements infringe on a woman’s constitutional rights to an abortion and violates the due process clause of the Fifth Amendment.
Government lawyers have argued that the requirements are necessary to ensure that patients safely use mifepristone. The FDA rule requires patients to pick up the single tablet of mifepristone at a hospital, clinic or medical office and sign a form that includes information about the medication’s potential risks.
The judge said suspending the requirements aligns with public health guidance to eliminate unnecessary travel and in-person contact.
Chuang granted the ACLU’s request for a preliminary injunction on due process grounds. He noted that federal regulators have waived in-person requirements for many other drugs “for the specific purpose of protecting public health.”
The group’s lawsuit says mifepristone is the only one of more than 20,000 FDA-regulated drugs that patients must receive in person at a hospital, clinic, or medical office “yet may self-administer, unsupervised, at a location of their choosing.”
The judge didn’t set any geographic limitations on the injunction. Referring to the nature of the pandemic, he said that “crafting relief that attempts to account for both the unpredictable changes and nuanced regional differences across 50 different states over an extended period of time is simply infeasible.”
The states of Indiana, Louisiana, Alabama, Arkansas, Idaho, Kentucky, Mississippi, Missouri, Nebraska and Oklahoma had asked to intervene in the lawsuit. The 10 states argued that the case could impact how they enforce their own state laws that relate to or reference the FDA’s regulation of mifepristone.
Chuang rejected their request last month. The judge said the federal case would not eliminate any state’s ability to continue to regulate medication abortion “above and beyond” the FDA’s requirements.
More than 4 million people in the U.S. have used mifepristone and misoprostol to end an early pregnancy; the two-drug combination accounted for 39% of all U.S. abortions in 2017, the lawsuit says.
The lawsuit says the FDA rule has “particularly severe implications for low-income people and people of color, who comprise a disproportionate share of impacted patients and who are already suffering and dying from COVID-19 at substantially higher rates.”
In March, dozens of anti-abortion advocates signed a letter to HHS Secretary Alex Azar in which they called for halting abortion procedures during the pandemic. “Their continued operation depletes sorely needed personal protective equipment and leads to complications that will further overwhelm already overextended emergency rooms,” the letter said.
Azar and FDA Commissioner Stephen Hahn also were named as defendants in the suit.
– – –
Michael Kunzelman is a reporter at The Associated Press.